PATHOZONE 258,5 mg/10 ml sospensione intramammaria per bovine da latte in lattazione
PATHOZONE 258,5 mg/10 ml sospensione intramammaria per bovine da latte in lattazione
Authorised
- Cefoperazone sodium
Product identification
Medicine name:
PATHOZONE 258,5 mg/10 ml sospensione intramammaria per bovine da latte in lattazione
Active substance:
- Cefoperazone sodium
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefoperazone sodium258.50/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal3day
-
Milk72hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DD12
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Available in:
-
Italy
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Italia S.r.l
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Italian (PDF)
Published on: 14/12/2022